(Q37882559)

24 August 2017

1 reference

title

Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit (English)

1 reference

24 August 2017

0 references

1 reference

1 reference

1 reference

Aryeh Shander

1

1 reference

PubMed ID

21626430

24 August 2017

Christopher E Walsh

series ordinal

2

1 reference

PubMed ID

21626430

24 August 2017

Caroline Cromwell

series ordinal

3

1 reference

24 August 2017

31 May 2011

1 reference

24 August 2017

Intensive Care Medicine

1 reference

24 August 2017

37

1 reference

24 August 2017

8

1 reference

24 August 2017

1240-1249

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-011-2258-5

24 August 2017

0 references

cites work

Coagulation abnormalities in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Coagulopathy in critically ill patients: part 1: platelet disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired haemophilia a in the elderly: case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired hemophilia A: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Advances in the understanding of acquired haemophilia A: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

A case of acute upper and lower airway obstruction due to retropharyngeal haemorrhage secondary to acquired haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

A 54-year-old woman with acute airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Recurrence of spontaneous subdural haematoma revealing acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Diagnosis and treatment of acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

The lupus anticoagulant/antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Coagulopathy in critically ill patients: part 2-soluble clotting factors and hemostatic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Screening and diagnosis of coagulation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Management of acquired haemophilia A - more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Platelet-dependent action of high-dose factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Treatment of acquired haemophilia with factor eight inhibitor bypassing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

FEIBA safety profile in multiple modes of clinical and home-therapy application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Multidisciplinary approach to the challenge of hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

21 January 2018

Hetastarch haemophilia

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2258-5

New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores

21 January 2018

1 reference

12 December 2020

Acquired haemophilia. A case report.

1 reference

12 December 2020

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

1 reference

12 December 2020

New protocol for immune tolerance induction in acquired hemophilia

1 reference

12 December 2020

New perspectives in hemophilia treatment

1 reference

12 December 2020

Inherited platelet disorders

1 reference

12 December 2020

Acquired disorders of platelet function

1 reference

12 December 2020

The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study

1 reference

12 December 2020

Use of porcine factor VIII in the treatment of patients with acquired hemophilia.

1 reference

12 December 2020

Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).

1 reference

12 December 2020

[Acquired haemophilia].

1 reference

12 December 2020

A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies

1 reference

12 December 2020

Acquired factor VIII inhibitors: pathophysiology and treatment

1 reference

12 December 2020

Acquired factor VIII inhibitor

1 reference

12 December 2020

Safety of recombinant activated factor VII in randomized clinical trials

1 reference

12 December 2020

10.1007/S00134-011-2258-5

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21626430